Factor XI Activation Inhibitors for Treating Thrombosis, Embolisms, Hypercoagulability, and Fibrotic Changes
- ACS Med Chem Lett. 2022 Mar 11;13(4):530-531. doi: 10.1021/acsmedchemlett.2c00086.
Affiliations
- 1. Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
PMID: 35450375
DOI: 10.1021/acsmedchemlett.2c00086
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Factor XIResearch Areas: Cardiovascular Disease